Skip to content

4Accepted Sep 24, 4:13 PM ET

UnitedHealth (UNH) Director John H. Noseworthy Receives 46-Share Award

UNHUNITEDHEALTH GROUP INC

Accepted (ET)

4:13 PM

Sep 24, 2026

Filed

Sep 24, 2026

Documents

1

Size

5.1 KB

Summary

UnitedHealth (UNH) Director John H. Noseworthy Receives 46-Share Award

Updated

What Happened John H. Noseworthy, a director of UnitedHealth Group (UNH), was credited with 46 shares on 2026-09-22. The Form 4 records an acquisition (code A) of 46 shares at $0.00 per share (total cash consideration $0). This transaction represents dividend equivalents paid on vested deferred stock units rather than an open-market purchase.

Key Details

  • Transaction date: 2026-09-22; Filing date: 2026-09-24 (timely).
  • Transaction type/code: Award/other acquisition (A).
  • Shares acquired: 46; Price per share: $0.00; Cash paid: $0.
  • Shares owned after transaction: not specified in the filing.
  • Footnote: Dividend equivalents on vested deferred stock units; these equivalents are immediately vested and follow the same terms as the underlying deferred stock units (F1).
  • No sale, 10b5-1 plan, or tax-withholding sale reported.

Context Dividend-equivalent share awards are typically routine compensation mechanics that convert dividends on deferred units into additional shares. Because this was an award (not a purchase or sale), it should be viewed as a compensation-related issuance rather than a direct trading signal about the director's view of the company.

AI-written summary · check the filing